ASCENSION ST JOHN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $5.4M
- Transactions
- 1,176
- Companies
- 40
- Average per transaction
- $4,629
Who reported the payments
| Pfizer | $2,017,460 |
| Medtronic | $774,965 |
| Jazz Pharmaceuticals Inc. | $571,858 |
| Genetesis, Inc. | $231,390 |
| Angiodynamics, Inc. | $227,511 |
| Genentech, Inc. | $211,414 |
| Gilead | $145,566 |
| AstraZeneca | $136,557 |
| Abbott | $128,347 |
| Penumbra, Inc. | $97,149 |
| Eli Lilly | $88,190 |
| Amgen | $83,373 |
| Saranas, Inc. | $77,584 |
| Olympus Corporation | $77,019 |
| Cardiovascular Systems Inc. | $64,232 |
| Impulse Dynamics (USA) Inc. | $57,570 |
| Viiv Healthcare Company | $47,026 |
| Boston Scientific | $37,210 |
| Philips North America LLC | $25,850 |
| EKOS Corporation | $23,576 |
| ERBE USA Inc | $22,000 |
| Biogen | $21,342 |
| Redhill Biopharma Inc. | $18,361 |
| Melinta Therapeutics, LLC | $17,894 |
| Pharmacyclics LLC, An Abbvie Company | $17,115 |
| Inspiremd Ltd | $16,716 |
| Stryker | $16,437 |
| Endologix LLC | $15,893 |
| Bristol Myers Squibb | $15,820 |
| E.r. Squibb & Sons, L.L.C. | $14,950 |
| AbbVie | $11,500 |
| Olympus Corporation Of The Americas | $11,000 |
| Bard Peripheral Vascular, Inc. | $10,810 |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,500 |
| Livanova USA, Inc. | $9,650 |
| Beone Medicines USA, Inc. | $8,750 |
| ZOLL Circulation Inc | $7,782 |
| Cook Incorporated | $7,000 |
| Olympus America Inc. | $7,000 |
| Merge Healthcare Incorporated | $6,895 |